TY - JOUR
T1 - Management of desmoid tumours
T2 - A nationwide survey of labelled reference centre networks in France
AU - Penel, Nicolas
AU - Coindre, Jean Michel
AU - Bonvalot, Sylvie
AU - Italiano, Antoine
AU - Neuville, Agnès
AU - Le Cesne, Axel
AU - Terrier, Philippe
AU - Ray-Coquard, Isabelle
AU - Ranchere-Vince, Dominique
AU - Robin, Yves Marie
AU - Isambert, Nicolas
AU - Ferron, Gwennaël
AU - Duffaud, Florence
AU - Bertucci, François
AU - Rios, Maria
AU - Stoeckle, Eberhad
AU - Le Pechoux, Cécile
AU - Guillemet, Cécile
AU - Courreges, Jean Baptiste
AU - Blay, Jean Yves
N1 - Publisher Copyright:
© 2016 Published by Elsevier Ltd.
PY - 2016/5/1
Y1 - 2016/5/1
N2 - Purpose The optimal management of rare tumours (i.e. from accurate diagnosis to management in reference centres) is a public health challenge. In 2009, the French National Cancer Institute (INCa) identified and financially supported the two expert networks for pathological and clinical diagnosis and management of soft tissue tumours. Methods The activities of both networks were prospectively collected using a nationwide database (rreps.org). Data describing the diagnosis management of 863 successive cases of desmoids tumours (DT) were prospectively collected from 2010 to 2013 and analysed. Results The number of confirmed DT constantly improved from January 2010 to December 2013 (from 173 to 273 cases per year); the expected incidence ranged from 132 to 330 cases/year. The rate of cases diagnosed with core-needle biopsies and CTNNB1 mutational status analysis increased from 30.6 to 40.7% and from 87.8 to 94.1%, respectively. The mean delay for pathological diagnosis confirmation constantly decreased from 107 to 47 d. Among the 846 adult patients, 414 (48.9%) patients were treated by reference centres. The rate of patients managed by reference centres constantly increased with time from 36.9 to 49.5% since 2010. The median management time of the referral centres constantly decreased from 440 to 67 d. Conclusion The two expert networks worked synergistically and improved diagnosis modalities of rare desmoid tumours at a national level. The impact of management by expert networks on the outcome will be prospectively analysed in the future.
AB - Purpose The optimal management of rare tumours (i.e. from accurate diagnosis to management in reference centres) is a public health challenge. In 2009, the French National Cancer Institute (INCa) identified and financially supported the two expert networks for pathological and clinical diagnosis and management of soft tissue tumours. Methods The activities of both networks were prospectively collected using a nationwide database (rreps.org). Data describing the diagnosis management of 863 successive cases of desmoids tumours (DT) were prospectively collected from 2010 to 2013 and analysed. Results The number of confirmed DT constantly improved from January 2010 to December 2013 (from 173 to 273 cases per year); the expected incidence ranged from 132 to 330 cases/year. The rate of cases diagnosed with core-needle biopsies and CTNNB1 mutational status analysis increased from 30.6 to 40.7% and from 87.8 to 94.1%, respectively. The mean delay for pathological diagnosis confirmation constantly decreased from 107 to 47 d. Among the 846 adult patients, 414 (48.9%) patients were treated by reference centres. The rate of patients managed by reference centres constantly increased with time from 36.9 to 49.5% since 2010. The median management time of the referral centres constantly decreased from 440 to 67 d. Conclusion The two expert networks worked synergistically and improved diagnosis modalities of rare desmoid tumours at a national level. The impact of management by expert networks on the outcome will be prospectively analysed in the future.
KW - Desmoid tumours
KW - Expert network
KW - Key indicators of activity
KW - Rare tumours
KW - Reference centres
UR - http://www.scopus.com/inward/record.url?scp=84960422441&partnerID=8YFLogxK
U2 - 10.1016/j.ejca.2016.02.008
DO - 10.1016/j.ejca.2016.02.008
M3 - Article
C2 - 26974708
AN - SCOPUS:84960422441
SN - 0959-8049
VL - 58
SP - 90
EP - 96
JO - European Journal of Cancer
JF - European Journal of Cancer
ER -